NP Istanbul Brain Hospital
| トルコ | オーストリア | スペイン | |
| 入院治療 | から $350 | から $1,200 | から $800 |
| 同行者の宿泊（1日分） | から $50 | から $150 | から $100 |
Bookimedは入院治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで入院治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。入院治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。入院治療の旅路でお一人になることはありません。
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Dr. Łukasz Maciejewski is a specialist in anesthesiology and intensive care medicine and in emergency medicine. He graduated from the Pomeranian Medical University in Szczecin. He completed additional training in Poland and Germany.
He gained clinical experience at the 109th Military Hospital in Szczecin. He also worked in German centers: Vivantes Klinikum im Friedrichshain (Berlin), Kreiskrankenhaus Wolgast gGmbH, and Asklepios Klinikum Uckermark (Schwedt/Oder).
He holds DEGUM certifications in ultrasonography and regional anesthesia (German Society for Ultrasound in Medicine). He supervises apheresis procedures at Nowoczesna Afereza. He speaks Polish, German, and English.
医師は2012年からBerounリハビリテーション病院のリハビリテーション部門の責任者を務めています。以前は2010年から2012年まで副主任を務めていました。医師は、Thomayer Faculty Hospital、Asklepios Klinik Schaufling、Motol Faculty Hospitalなどの様々な著名な医療機関でリハビリテーション医としての豊富な経験を持ち、整形外科リハビリテーション、神経学、心臓病学、高齢医学に焦点を当てています。
1984年にプラハのカレル大学第一医学部を卒業しました。アルギアトリー、物理医学とリハビリテーション、産科と婦人科の専門資格を持っています。医師はまた、プライベートプラクティスを指導し、この分野で教えるライセンスを持っています。